Aarti Drugs Live BSE/NSE | Aarti Drugs Fundamenta data | Aarti Drugs Balance sheet | Aarti Drugs Quarterly Results | Aarti Drugs Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,501.17
26.28
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,871.47
0.07%
7.36

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.68
9.64
13.24

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.40
8.11
5.63

PAT CAGR (%)

10 Years
5 Years
3 Years

19.66
15.52
19.77

P:E (Median)

8 Years
5 Years
3 Years

16.61
16.37
15.50

P:BV (Average)

8 Years
5 Years
3 Years

3.58
3.50
3.60

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.40
10.24
10.53

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 515.16 442.71 16.37% 475.55 370.02 28.52% 406.57 432.54 -6.00% 415.61 350.65 18.53%
Expenses 406.18 377.49 7.60% 359.45 317.72 13.13% 338.97 380.05 -10.81% 356.31 299.70 18.89%
EBITDA 108.98 65.22 67.10% 116.10 52.30 121.99% 67.60 52.49 28.79% 59.30 50.95 16.39%
EBIDTM 21.15% 14.73% 24.41% 14.13% 16.63% 12.14% 14.27% 14.53%
Other Income 0.26 0.21 23.81% 1.24 0.10 1,140.00% 0.61 1.27 -51.97% 0.13 0.21 -38.10%
Interest 6.98 8.08 -13.61% 6.39 8.79 -27.30% 7.24 9.73 -25.59% 8.08 9.87 -18.14%
Depreciation 11.97 11.55 3.64% 11.92 11.29 5.58% 11.99 10.28 16.63% 11.85 10.24 15.72%
PBT 90.29 45.80 97.14% 99.03 32.32 206.40% 57.36 37.52 52.88% 39.51 31.05 27.25%
Tax 20.50 15.00 36.67% 26.00 10.75 141.86% 0.80 11.82 -93.23% 12.75 9.90 28.79%
PAT 69.79 30.80 126.59% 73.03 21.57 238.57% 56.56 25.70 120.08% 26.76 21.15 26.52%
PATM 13.55% 6.96% 15.36% 5.83% 13.91% 5.94% 6.44% 6.03%
EPS 7.49 3.30 126.97% 7.84 2.31 239.39% 6.07 2.76 119.93% 2.87 2.27 26.43%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 578.11 477.50 21.07% 544.67 405.43 34.34% 449.64 459.14 -2.07% 473.51 380.11 24.57%
Expenses 461.67 409.20 12.82% 410.70 350.71 17.11% 378.33 403.23 -6.18% 406.02 328.26 23.69%
EBITDA 116.44 68.30 70.48% 133.97 54.72 144.83% 71.31 55.91 27.54% 67.49 51.85 30.16%
EBIDTM 20.14% 14.30% 24.60% 13.50% 15.86% 12.18% 14.25% 13.64%
Other Income 0.29 0.19 52.63% 1.26 0.06 2,000.00% 0.98 1.22 -19.67% 0.25 0.17 47.06%
Interest 7.05 8.54 -17.45% 6.57 9.33 -29.58% 7.47 10.34 -27.76% 8.39 10.48 -19.94%
Depreciation 12.56 12.09 3.89% 12.38 11.81 4.83% 12.49 10.81 15.54% 12.36 10.72 15.30%
PBT 97.12 47.86 102.93% 116.28 33.64 245.66% 60.71 39.75 52.73% 43.08 30.81 39.82%
Tax 21.85 15.55 40.51% 30.83 11.18 175.76% 1.85 12.31 -84.97% 15.30 9.94 53.92%
PAT 75.27 32.31 132.96% 85.45 22.46 280.45% 58.86 27.44 114.50% 27.78 20.87 33.11%
PATM 13.02% 6.77% 15.69% 5.54% 13.09% 5.98% 5.87% 5.49%
EPS 8.08 3.47 132.85% 9.17 2.41 280.50% 6.32 2.91 117.18% 2.98 2.21 34.84%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,812.89 1,634.92 1,454.25 1,140.46 1,088.72 1,075.50 1,087.22 971.75 825.75 662.34 496.42 Net Sales Growth 13.60% 12.42% 27.51% 4.75% 1.23% -1.08% 11.88% 17.68% 24.67% 33.42% Cost Of Goods Sold 1,126.04 1,028.03 950.77 686.64 673.19 690.90 717.77 642.52 536.36 437.67 328.71 Gross Profit 686.85 606.89 503.48 453.82 415.53 384.59 369.45 329.23 289.39 224.67 167.72 GP Margin 37.89% 37.12% 34.62% 39.79% 38.17% 35.76% 33.98% 33.88% 35.05% 33.92% 33.79% Total Expenditure 1,460.91 1,386.98 1,251.51 955.32 909.74 899.74 914.93 821.71 702.58 579.38 431.65 Power & Fuel Cost - 101.04 82.14 68.97 56.61 52.64 49.30 47.84 53.27 47.51 28.65 % Of Sales - 6.18% 5.65% 6.05% 5.20% 4.89% 4.53% 4.92% 6.45% 7.17% 5.77% Employee Cost - 52.65 47.23 45.12 42.76 36.93 32.68 28.51 25.25 21.59 16.46 % Of Sales - 3.22% 3.25% 3.96% 3.93% 3.43% 3.01% 2.93% 3.06% 3.26% 3.32% Manufacturing Exp. - 139.77 121.08 108.53 90.77 77.25 73.58 59.39 53.49 44.73 37.58 % Of Sales - 8.55% 8.33% 9.52% 8.34% 7.18% 6.77% 6.11% 6.48% 6.75% 7.57% General & Admin Exp. - 18.53 12.51 10.79 10.39 9.85 10.21 9.73 7.85 6.83 4.58 % Of Sales - 1.13% 0.86% 0.95% 0.95% 0.92% 0.94% 1.00% 0.95% 1.03% 0.92% Selling & Distn. Exp. - 41.55 34.95 31.58 30.35 27.78 28.95 29.27 23.78 19.79 14.76 % Of Sales - 2.54% 2.40% 2.77% 2.79% 2.58% 2.66% 3.01% 2.88% 2.99% 2.97% Miscellaneous Exp. - 5.40 2.83 3.69 5.67 4.38 2.43 4.45 2.58 1.25 14.76 % Of Sales - 0.33% 0.19% 0.32% 0.52% 0.41% 0.22% 0.46% 0.31% 0.19% 0.18% EBITDA 351.98 247.94 202.74 185.14 178.98 175.76 172.29 150.04 123.17 82.96 64.77 EBITDA Margin 19.42% 15.17% 13.94% 16.23% 16.44% 16.34% 15.85% 15.44% 14.92% 12.53% 13.05% Other Income 2.24 1.06 2.51 1.17 3.53 0.00 0.65 0.02 0.00 0.00 0.08 Interest 28.69 35.74 41.00 36.30 38.05 47.34 42.21 37.18 30.87 25.36 15.63 Depreciation 47.73 46.67 40.39 37.80 36.69 35.58 30.66 28.12 25.98 24.22 17.74 PBT 286.19 166.60 123.86 112.21 107.78 92.84 100.06 84.76 66.31 33.38 31.47 Tax 60.05 39.30 40.37 38.80 32.30 26.55 22.47 23.97 20.64 9.76 9.00 Tax Rate 20.98% 22.46% 31.63% 34.58% 29.97% 28.60% 22.46% 28.28% 31.13% 30.29% 28.60% PAT 226.14 135.67 87.26 73.41 75.48 66.29 77.60 60.80 45.67 22.46 22.47 PAT before Minority Interest 226.14 135.67 87.26 73.41 75.48 66.29 77.60 60.80 45.67 22.46 22.47 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.47% 8.30% 6.00% 6.44% 6.93% 6.16% 7.14% 6.26% 5.53% 3.39% 4.53% PAT Growth 127.92% 55.48% 18.87% -2.74% 13.86% -14.57% 27.63% 33.13% 103.34% -0.04% Unadjusted EPS 24.26 14.56 9.36 7.88 8.10 7.11 8.33 6.52 4.90 2.41 2.41

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

1,812.89

1,634.92

1,454.25

1,140.46

1,088.72

1,075.50

1,087.22

971.75

825.75

662.34

496.42

Net Sales Growth

13.60%

12.42%

27.51%

4.75%

1.23%

-1.08%

11.88%

17.68%

24.67%

33.42%

Cost Of Goods Sold

1,126.04

1,028.03

950.77

686.64

673.19

690.90

717.77

642.52

536.36

437.67

328.71

Gross Profit

686.85

606.89

503.48

453.82

415.53

384.59

369.45

329.23

289.39

224.67

167.72

GP Margin

37.89%

37.12%

34.62%

39.79%

38.17%

35.76%

33.98%

33.88%

35.05%

33.92%

33.79%

Total Expenditure

1,460.91

1,386.98

1,251.51

955.32

909.74

899.74

914.93

821.71

702.58

579.38

431.65

Power & Fuel Cost

101.04

82.14

68.97

56.61

52.64

49.30

47.84

53.27

47.51

28.65

% Of Sales

6.18%

5.65%

6.05%

5.20%

4.89%

4.53%

4.92%

6.45%

7.17%

5.77%

Employee Cost

52.65

47.23

45.12

42.76

36.93

32.68

28.51

25.25

21.59

16.46

% Of Sales

3.22%

3.25%

3.96%

3.93%

3.43%

3.01%

2.93%

3.06%

3.26%

3.32%

Manufacturing Exp.

139.77

121.08

108.53

90.77

77.25

73.58

59.39

53.49

44.73

37.58

% Of Sales

8.55%

8.33%

9.52%

8.34%

7.18%

6.77%

6.11%

6.48%

6.75%

7.57%

General & Admin Exp.

18.53

12.51

10.79

10.39

9.85

10.21

9.73

7.85

6.83

4.58

% Of Sales

1.13%

0.86%

0.95%

0.92%

0.94%

1.00%

0.95%

1.03%

0.92%

Selling & Distn. Exp.

41.55

34.95

31.58

30.35

27.78

28.95

29.27

23.78

19.79

14.76

% Of Sales

2.54%

2.40%

2.77%

2.79%

2.58%

2.66%

3.01%

2.88%

2.99%

2.97%

Miscellaneous Exp.

5.40

2.83

3.69

5.67

4.38

2.43

4.45

2.58

1.25

14.76

% Of Sales

0.33%

0.19%

0.32%

0.52%

0.41%

0.22%

0.46%

0.31%

0.19%

0.18%

EBITDA

351.98

247.94

202.74

185.14

178.98

175.76

172.29

150.04

123.17

82.96

64.77

EBITDA Margin

19.42%

15.17%

13.94%

16.23%

16.44%

16.34%

15.85%

15.44%

14.92%

12.53%

13.05%

Other Income

2.24

1.06

2.51

1.17

3.53

0.00

0.65

0.02

0.00

0.08

Interest

28.69

35.74

41.00

36.30

38.05

47.34

42.21

37.18

30.87

25.36

15.63

Depreciation

47.73

46.67

40.39

37.80

36.69

35.58

30.66

28.12

25.98

24.22

17.74

PBT

286.19

166.60

123.86

112.21

107.78

92.84

100.06

84.76

66.31

33.38

31.47

Tax

60.05

39.30

40.37

38.80

32.30

26.55

22.47

23.97

20.64

9.76

9.00

Tax Rate

20.98%

22.46%

31.63%

34.58%

29.97%

28.60%

22.46%

28.28%

31.13%

30.29%

28.60%

PAT

226.14

135.67

87.26

73.41

75.48

66.29

77.60

60.80

45.67

22.46

22.47

PAT before Minority Interest

226.14

135.67

87.26

73.41

75.48

66.29

77.60

60.80

45.67

22.46

22.47

Minority Interest

0.00

PAT Margin

12.47%

8.30%

6.00%

6.44%

6.93%

6.16%

7.14%

6.26%

5.53%

3.39%

4.53%

PAT Growth

127.92%

55.48%

18.87%

-2.74%

13.86%

-14.57%

27.63%

33.13%

103.34%

-0.04%

Unadjusted EPS

24.26

14.56

9.36

7.88

8.10

7.11

8.33

6.52

4.90

2.41

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11 Mar 10 Mar 09 Mar 08
Net Sales 2,045.93 1,806.09 1,560.94 1,243.63 1,195.17 1,139.84 1,096.88 501.05 478.50 382.12 312.36 Net Sales Growth 18.80% 15.71% 25.51% 4.05% 4.85% 3.92% 118.92% 4.71% 25.22% 22.33% Cost Of Goods Sold 1,271.11 1,127.29 1,013.53 737.72 744.43 735.08 724.24 321.34 301.35 238.85 197.35 Gross Profit 774.82 678.79 547.40 505.91 450.75 404.77 372.65 179.71 177.15 143.27 115.01 GP Margin 37.87% 37.58% 35.07% 40.68% 37.71% 35.51% 33.97% 35.87% 37.02% 37.49% 36.82% Total Expenditure 1,656.72 1,540.57 1,350.03 1,041.76 1,004.68 960.02 924.51 431.87 396.04 315.67 266.61 Power & Fuel Cost - 103.83 84.39 71.42 59.42 53.93 49.56 29.07 26.48 23.27 19.70 % Of Sales - 5.75% 5.41% 5.74% 4.97% 4.73% 4.52% 5.80% 5.53% 6.09% 6.31% Employee Cost - 61.35 54.55 52.14 47.95 40.19 33.26 19.93 14.77 12.00 10.54 % Of Sales - 3.40% 3.49% 4.19% 4.01% 3.53% 3.03% 3.98% 3.09% 3.14% 3.37% Manufacturing Exp. - 160.38 142.69 130.01 103.21 87.60 75.53 39.18 32.32 25.17 24.22 % Of Sales - 8.88% 9.14% 10.45% 8.64% 7.69% 6.89% 7.82% 6.75% 6.59% 7.75% General & Admin Exp. - 21.39 14.24 12.22 12.81 10.98 10.48 4.86 4.95 3.80 3.14 % Of Sales - 1.18% 0.91% 0.98% 1.07% 0.96% 0.96% 0.97% 1.03% 0.99% 1.01% Selling & Distn. Exp. - 59.46 37.51 34.00 31.16 27.82 28.99 16.21 14.47 11.69 9.99 % Of Sales - 3.29% 2.40% 2.73% 2.61% 2.44% 2.64% 3.24% 3.02% 3.06% 3.20% Miscellaneous Exp. - 6.88 3.11 4.24 5.71 4.42 2.45 1.27 1.71 0.89 9.99 % Of Sales - 0.38% 0.20% 0.34% 0.48% 0.39% 0.22% 0.25% 0.36% 0.23% 0.53% EBITDA 389.21 265.52 210.91 201.87 190.49 179.82 172.37 69.18 82.46 66.45 45.75 EBITDA Margin 19.02% 14.70% 13.51% 16.23% 15.94% 15.78% 15.71% 13.81% 17.23% 17.39% 14.65% Other Income 2.78 1.48 2.41 1.05 4.00 0.00 0.65 0.16 0.63 0.52 1.85 Interest 29.48 37.42 43.51 38.36 40.02 48.02 42.28 17.12 18.66 26.45 14.48 Depreciation 49.79 48.75 42.56 40.06 38.46 36.53 31.02 19.11 17.03 14.48 13.02 PBT 317.19 180.82 127.26 124.50 116.01 95.27 99.72 33.11 47.40 26.04 20.09 Tax 69.83 43.89 41.27 42.20 34.21 26.55 22.47 9.61 18.96 8.47 5.28 Tax Rate 22.02% 23.69% 31.50% 33.90% 29.49% 27.87% 22.53% 29.02% 40.00% 32.53% 26.28% PAT 247.36 141.40 89.75 82.31 81.80 68.72 77.25 23.50 28.06 16.71 14.08 PAT before Minority Interest 247.37 141.40 89.75 82.31 81.80 68.72 77.25 23.50 28.44 17.57 14.81 Minority Interest 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 -0.86 -0.73 PAT Margin 12.09% 7.83% 5.75% 6.62% 6.84% 6.03% 7.04% 4.69% 5.86% 4.37% 4.51% PAT Growth 139.97% 57.55% 9.04% 0.62% 19.03% -11.04% 228.72% -16.25% 67.92% 18.68% Unadjusted EPS 26.54 15.17 9.63 8.83 8.78 7.37 8.29 2.52 3.01 1.79 1.51

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 11

Mar 10

Mar 09

Mar 08

Net Sales

2,045.93

1,806.09

1,560.94

1,243.63

1,195.17

1,139.84

1,096.88

501.05

478.50

382.12

312.36

Net Sales Growth

18.80%

15.71%

25.51%

4.05%

4.85%

3.92%

118.92%

4.71%

25.22%

22.33%

Cost Of Goods Sold

1,271.11

1,127.29

1,013.53

737.72

744.43

735.08

724.24

321.34

301.35

238.85

197.35

Gross Profit

774.82

678.79

547.40

505.91

450.75

404.77

372.65

179.71

177.15

143.27

115.01

GP Margin

37.87%

37.58%

35.07%

40.68%

37.71%

35.51%

33.97%

35.87%

37.02%

37.49%

36.82%

Total Expenditure

1,656.72

1,540.57

1,350.03

1,041.76

1,004.68

960.02

924.51

431.87

396.04

315.67

266.61

Power & Fuel Cost

103.83

84.39

71.42

59.42

53.93

49.56

29.07

26.48

23.27

19.70

% Of Sales

5.75%

5.41%

5.74%

4.97%

4.73%

4.52%

5.80%

5.53%

6.09%

6.31%

Employee Cost

61.35

54.55

52.14

47.95

40.19

33.26

19.93

14.77

12.00

10.54

% Of Sales

3.40%

3.49%

4.19%

4.01%

3.53%

3.03%

3.98%

3.09%

3.14%

3.37%

Manufacturing Exp.

160.38

142.69

130.01

103.21

87.60

75.53

39.18

32.32

25.17

24.22

% Of Sales

8.88%

9.14%

10.45%

8.64%

7.69%

6.89%

7.82%

6.75%

6.59%

7.75%

General & Admin Exp.

21.39

14.24

12.22

12.81

10.98

10.48

4.86

4.95

3.80

3.14

% Of Sales

1.18%

0.91%

0.98%

1.07%

0.96%

0.97%

1.03%

0.99%

1.01%

Selling & Distn. Exp.

59.46

37.51

34.00

31.16

27.82

28.99

16.21

14.47

11.69

9.99

% Of Sales

3.29%

2.40%

2.73%

2.61%

2.44%

2.64%

3.24%

3.02%

3.06%

3.20%

Miscellaneous Exp.

6.88

3.11

4.24

5.71

4.42

2.45

1.27

1.71

0.89

9.99

% Of Sales

0.38%

0.20%

0.34%

0.48%

0.39%

0.22%

0.25%

0.36%

0.23%

0.53%

EBITDA

389.21

265.52

210.91

201.87

190.49

179.82

172.37

69.18

82.46

66.45

45.75

EBITDA Margin

19.02%

14.70%

13.51%

16.23%

15.94%

15.78%

15.71%

13.81%

17.23%

17.39%

14.65%

Other Income

2.78

1.48

2.41

1.05

4.00

0.00

0.65

0.16

0.63

0.52

1.85

Interest

29.48

37.42

43.51

38.36

40.02

48.02

42.28

17.12

18.66

26.45

14.48

Depreciation

49.79

48.75

42.56

40.06

38.46

36.53

31.02

19.11

17.03

14.48

13.02

PBT

317.19

180.82

127.26

124.50

116.01

95.27

99.72

33.11

47.40

26.04

20.09

Tax

69.83

43.89

41.27

42.20

34.21

26.55

22.47

9.61

18.96

8.47

5.28

Tax Rate

22.02%

23.69%

31.50%

33.90%

29.49%

27.87%

22.53%

29.02%

40.00%

32.53%

26.28%

PAT

247.36

141.40

89.75

82.31

81.80

68.72

77.25

23.50

28.06

16.71

14.08

PAT before Minority Interest

247.37

141.40

89.75

82.31

81.80

68.72

77.25

23.50

28.44

17.57

14.81

Minority Interest

0.01

0.00

-0.38

-0.86

-0.73

PAT Margin

12.09%

7.83%

5.75%

6.62%

6.84%

6.03%

7.04%

4.69%

5.86%

4.37%

4.51%

PAT Growth

139.97%

57.55%

9.04%

0.62%

19.03%

-11.04%

228.72%

-16.25%

67.92%

18.68%

Unadjusted EPS

26.54

15.17

9.63

8.83

8.78

7.37

8.29

2.52

3.01

1.79

1.51

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 621.79 518.58 433.17 386.97 350.31 303.70 250.90 207.61 176.48 156.52 Share Capital 23.30 23.58 23.58 23.86 24.22 24.22 12.11 12.11 12.11 12.11 Total Reserves 598.49 494.99 409.59 363.11 326.10 279.49 238.80 195.50 164.37 144.41 Non-Current Liabilities 292.91 307.00 294.33 279.97 227.31 198.83 119.16 121.11 99.11 104.21 Secured Loans 167.71 186.69 173.99 173.28 160.64 140.72 76.64 67.50 66.92 74.34 Unsecured Loans 8.57 8.57 12.17 14.17 14.57 10.75 0.00 13.21 0.00 0.00 Long Term Provisions 23.62 12.80 16.87 8.66 1.42 0.29 0.00 2.86 0.00 0.00 Current Liabilities 555.99 547.36 588.74 449.18 477.08 464.40 479.67 391.00 337.03 255.17 Trade Payables 316.37 228.43 239.67 170.30 164.18 150.19 150.18 131.89 93.79 77.36 Other Current Liabilities 81.36 71.15 51.94 47.63 42.24 41.19 44.18 30.24 28.66 24.16 Short Term Borrowings 154.61 246.34 296.24 229.57 257.37 251.27 265.60 214.98 205.57 147.23 Short Term Provisions 3.65 1.43 0.89 1.68 13.28 21.76 19.71 13.89 9.02 6.41 Total Liabilities 1,470.69 1,372.94 1,316.24 1,116.12 1,054.70 966.93 849.73 719.72 612.62 515.90 Net Block 611.57 585.67 563.59 542.32 462.77 431.48 372.53 291.23 273.54 224.21 Gross Block 991.25 920.74 862.31 803.53 690.74 665.09 581.13 479.05 439.38 345.80 Accumulated Depreciation 379.68 335.07 298.72 261.21 227.97 233.61 208.60 187.82 165.85 121.59 Non Current Assets 645.33 637.93 619.59 586.64 512.67 460.19 392.50 311.51 285.71 267.82 Capital Work in Progress 10.96 32.37 27.99 14.13 34.04 13.35 8.32 12.59 2.99 10.37 Non Current Investment 20.38 18.92 17.24 18.42 11.12 11.11 4.62 5.13 6.92 24.61 Long Term Loans & Adv. 2.42 0.97 10.77 11.76 4.74 4.24 7.04 2.56 2.27 8.63 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 825.36 735.00 696.65 529.48 542.03 506.74 457.24 408.21 326.91 248.07 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 307.41 227.71 254.10 188.75 167.05 153.36 126.73 140.92 97.91 83.16 Sundry Debtors 464.34 436.90 365.23 278.27 321.19 307.59 276.52 215.67 180.60 125.83 Cash & Bank 3.85 4.85 3.91 4.00 4.50 3.43 4.40 2.88 4.94 3.59 Other Current Assets 49.77 6.56 10.21 0.00 49.28 42.36 49.59 48.74 43.46 35.49 Short Term Loans & Adv. 47.50 59.00 63.19 58.45 49.28 42.36 40.86 31.94 30.46 25.18 Net Current Assets 269.37 187.65 107.92 80.30 64.95 42.34 -22.44 17.21 -10.13 -7.10 Total Assets 1,470.69 1,372.93 1,316.24 1,116.12 1,054.70 966.93 849.74 719.72 612.62 515.89

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

621.79

518.58

433.17

386.97

350.31

303.70

250.90

207.61

176.48

156.52

Share Capital

23.30

23.58

23.86

24.22

12.11

Total Reserves

598.49

494.99

409.59

363.11

326.10

279.49

238.80

195.50

164.37

144.41

Non-Current Liabilities

292.91

307.00

294.33

279.97

227.31

198.83

119.16

121.11

99.11

104.21

Secured Loans

167.71

186.69

173.99

173.28

160.64

140.72

76.64

67.50

66.92

74.34

Unsecured Loans

8.57

12.17

14.17

14.57

10.75

0.00

13.21

0.00

Long Term Provisions

23.62

12.80

16.87

8.66

1.42

0.29

0.00

2.86

0.00

Current Liabilities

555.99

547.36

588.74

449.18

477.08

464.40

479.67

391.00

337.03

255.17

Trade Payables

316.37

228.43

239.67

170.30

164.18

150.19

150.18

131.89

93.79

77.36

Other Current Liabilities

81.36

71.15

51.94

47.63

42.24

41.19

44.18

30.24

28.66

24.16

Short Term Borrowings

154.61

246.34

296.24

229.57

257.37

251.27

265.60

214.98

205.57

147.23

Short Term Provisions

3.65

1.43

0.89

1.68

13.28

21.76

19.71

13.89

9.02

6.41

Total Liabilities

1,470.69

1,372.94

1,316.24

1,116.12

1,054.70

966.93

849.73

719.72

612.62

515.90

Net Block

611.57

585.67

563.59

542.32

462.77

431.48

372.53

291.23

273.54

224.21

Gross Block

991.25

920.74

862.31

803.53

690.74

665.09

581.13

479.05

439.38

345.80

Accumulated Depreciation

379.68

335.07

298.72

261.21

227.97

233.61

208.60

187.82

165.85

121.59

Non Current Assets

645.33

637.93

619.59

586.64

512.67

460.19

392.50

311.51

285.71

267.82

Capital Work in Progress

10.96

32.37

27.99

14.13

34.04

13.35

8.32

12.59

2.99

10.37

Non Current Investment

20.38

18.92

17.24

18.42

11.12

11.11

4.62

5.13

6.92

24.61

Long Term Loans & Adv.

2.42

0.97

10.77

11.76

4.74

4.24

7.04

2.56

2.27

8.63

Other Non Current Assets

0.00

Current Assets

825.36

735.00

696.65

529.48

542.03

506.74

457.24

408.21

326.91

248.07

Current Investments

0.00

Inventories

307.41

227.71

254.10

188.75

167.05

153.36

126.73

140.92

97.91

83.16

Sundry Debtors

464.34

436.90

365.23

278.27

321.19

307.59

276.52

215.67

180.60

125.83

Cash & Bank

3.85

4.85

3.91

4.00

4.50

3.43

4.40

2.88

4.94

3.59

Other Current Assets

49.77

6.56

10.21

0.00

49.28

42.36

49.59

48.74

43.46

35.49

Short Term Loans & Adv.

47.50

59.00

63.19

58.45

49.28

42.36

40.86

31.94

30.46

25.18

Net Current Assets

269.37

187.65

107.92

80.30

64.95

42.34

-22.44

17.21

-10.13

-7.10

Total Assets

1,470.69

1,372.93

1,316.24

1,116.12

1,054.70

966.93

849.74

719.72

612.62

515.89

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11 Mar 10 Mar 09 Mar 08
Shareholder's Funds 652.49 543.45 455.43 400.13 357.40 308.15 163.16 146.45 123.45 111.53 Share Capital 23.30 23.58 23.58 23.86 24.22 24.22 12.11 12.11 11.71 11.71 Total Reserves 629.19 519.86 431.85 376.27 333.18 283.94 151.05 134.34 111.53 99.82 Non-Current Liabilities 299.31 321.06 312.31 296.59 243.78 211.03 290.20 209.85 210.70 233.12 Secured Loans 171.74 199.64 190.53 187.38 176.66 152.72 204.83 138.66 160.86 127.57 Unsecured Loans 8.57 8.57 12.17 14.17 14.57 10.75 62.65 50.16 31.35 89.58 Long Term Provisions 23.63 12.32 16.87 8.39 1.42 0.29 0.00 0.00 0.00 0.00 Current Liabilities 624.70 590.98 621.68 494.31 501.02 482.76 70.10 57.99 59.62 57.40 Trade Payables 329.55 242.63 258.73 196.97 184.90 166.72 65.30 50.18 54.78 54.50 Other Current Liabilities 132.83 82.94 56.42 51.00 43.80 41.53 1.77 1.68 1.33 0.80 Short Term Borrowings 157.73 263.25 305.64 244.66 258.41 252.43 0.00 0.00 0.00 0.00 Short Term Provisions 4.59 2.16 0.89 1.68 13.91 22.08 3.03 6.13 3.51 2.11 Total Liabilities 1,576.50 1,455.49 1,389.42 1,191.03 1,102.20 1,001.94 523.46 419.15 403.24 416.63 Net Block 643.81 624.86 602.39 581.09 493.42 448.46 247.84 208.20 205.24 189.94 Gross Block 1,030.97 970.09 909.20 848.13 725.47 685.21 393.33 332.42 309.85 277.70 Accumulated Depreciation 387.16 345.22 306.81 267.04 232.05 236.75 145.49 124.21 104.61 87.76 Non Current Assets 672.50 671.20 652.55 619.61 536.97 476.40 263.50 213.35 207.43 217.81 Capital Work in Progress 12.21 32.75 28.45 14.28 34.04 16.06 10.37 3.40 0.64 14.67 Non Current Investment 13.36 12.44 10.76 11.94 4.63 4.63 5.28 1.74 1.55 13.20 Long Term Loans & Adv. 3.12 1.15 10.95 12.30 4.88 7.24 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 904.00 784.29 736.86 571.42 565.23 525.54 259.96 205.81 195.80 198.80 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 325.40 246.61 278.21 209.63 178.35 164.20 91.83 64.41 60.52 66.21 Sundry Debtors 488.63 458.54 374.94 296.81 331.69 314.27 121.34 115.87 113.48 103.29 Cash & Bank 7.64 5.55 4.27 4.17 4.82 3.58 5.27 8.52 3.48 4.02 Other Current Assets 82.32 6.56 10.21 0.00 50.37 43.49 41.52 17.01 18.32 25.27 Short Term Loans & Adv. 75.50 67.02 69.23 60.81 50.37 43.49 40.62 16.01 17.52 24.49 Net Current Assets 279.30 193.31 115.19 77.11 64.20 42.78 189.86 147.82 136.18 141.39 Total Assets 1,576.50 1,455.49 1,389.41 1,191.03 1,102.20 1,001.94 523.46 419.16 403.23 416.65

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 11

Mar 10

Mar 09

Mar 08

Shareholder's Funds

652.49

543.45

455.43

400.13

357.40

308.15

163.16

146.45

123.45

111.53

Share Capital

23.30

23.58

23.86

24.22

12.11

11.71

Total Reserves

629.19

519.86

431.85

376.27

333.18

283.94

151.05

134.34

111.53

99.82

Non-Current Liabilities

299.31

321.06

312.31

296.59

243.78

211.03

290.20

209.85

210.70

233.12

Secured Loans

171.74

199.64

190.53

187.38

176.66

152.72

204.83

138.66

160.86

127.57

Unsecured Loans

8.57

12.17

14.17

14.57

10.75

62.65

50.16

31.35

89.58

Long Term Provisions

23.63

12.32

16.87

8.39

1.42

0.29

0.00

Current Liabilities

624.70

590.98

621.68

494.31

501.02

482.76

70.10

57.99

59.62

57.40

Trade Payables

329.55

242.63

258.73

196.97

184.90

166.72

65.30

50.18

54.78

54.50

Other Current Liabilities

132.83

82.94

56.42

51.00

43.80

41.53

1.77

1.68

1.33

0.80

Short Term Borrowings

157.73

263.25

305.64

244.66

258.41

252.43

0.00

Short Term Provisions

4.59

2.16

0.89

1.68

13.91

22.08

3.03

6.13

3.51

2.11

Total Liabilities

1,576.50

1,455.49

1,389.42

1,191.03

1,102.20

1,001.94

523.46

419.15

403.24

416.63

Net Block

643.81

624.86

602.39

581.09

493.42

448.46

247.84

208.20

205.24

189.94

Gross Block

1,030.97

970.09

909.20

848.13

725.47

685.21

393.33

332.42

309.85

277.70

Accumulated Depreciation

387.16

345.22

306.81

267.04

232.05

236.75

145.49

124.21

104.61

87.76

Non Current Assets

672.50

671.20

652.55

619.61

536.97

476.40

263.50

213.35

207.43

217.81

Capital Work in Progress

12.21

32.75

28.45

14.28

34.04

16.06

10.37

3.40

0.64

14.67

Non Current Investment

13.36

12.44

10.76

11.94

4.63

5.28

1.74

1.55

13.20

Long Term Loans & Adv.

3.12

1.15

10.95

12.30

4.88

7.24

0.00

Other Non Current Assets

0.00

Current Assets

904.00

784.29

736.86

571.42

565.23

525.54

259.96

205.81

195.80

198.80

Current Investments

0.00

Inventories

325.40

246.61

278.21

209.63

178.35

164.20

91.83

64.41

60.52

66.21

Sundry Debtors

488.63

458.54

374.94

296.81

331.69

314.27

121.34

115.87

113.48

103.29

Cash & Bank

7.64

5.55

4.27

4.17

4.82

3.58

5.27

8.52

3.48

4.02

Other Current Assets

82.32

6.56

10.21

0.00

50.37

43.49

41.52

17.01

18.32

25.27

Short Term Loans & Adv.

75.50

67.02

69.23

60.81

50.37

43.49

40.62

16.01

17.52

24.49

Net Current Assets

279.30

193.31

115.19

77.11

64.20

42.78

189.86

147.82

136.18

141.39

Total Assets

1,576.50

1,455.49

1,389.41

1,191.03

1,102.20

1,001.94

523.46

419.16

403.23

416.65

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 196.15 147.30 61.93 174.41 125.27 106.83 95.43 72.31 44.43 28.40 PBT 174.97 127.62 112.21 107.78 92.84 100.06 84.76 66.31 32.22 31.47 Adjustment 79.82 70.77 71.06 68.20 78.20 68.73 61.31 53.44 49.89 33.42 Changes in Working Capital -21.34 -22.19 -99.42 17.93 -25.75 -47.03 -24.09 -33.89 -30.73 -27.76 Cash after chg. in Working capital 233.46 176.21 83.85 193.91 145.29 121.77 121.98 85.86 51.38 37.13 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -37.32 -28.91 -21.92 -19.51 -20.02 -14.94 -26.56 -13.56 -6.95 -8.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -29.35 -59.33 -71.09 -96.29 -87.40 -102.30 -104.67 -58.04 -47.74 -73.60 Net Fixed Assets -49.10 -62.81 -72.64 -92.88 -46.34 -88.99 -97.81 -49.27 -86.20 -65.29 Net Investments -1.46 -1.68 1.18 -7.30 -0.01 -6.49 0.51 1.79 17.69 -3.23 Others 21.21 5.16 0.37 3.89 -41.05 -6.82 -7.37 -10.56 20.77 -5.08 Cash from Financing Activity -167.76 -86.96 9.12 -78.42 -36.79 -5.49 10.76 -16.33 2.98 45.13 Net Cash Inflow / Outflow -0.96 1.01 -0.04 -0.31 1.07 -0.97 1.52 -2.07 -0.33 -0.06 Opening Cash & Equivalents 3.94 2.93 2.97 3.28 3.43 4.40 2.88 4.94 5.27 3.65 Closing Cash & Equivalent 2.98 3.94 2.93 2.97 4.50 3.43 4.40 2.88 4.94 3.59

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

196.15

147.30

61.93

174.41

125.27

106.83

95.43

72.31

44.43

28.40

PBT

174.97

127.62

112.21

107.78

92.84

100.06

84.76

66.31

32.22

31.47

Adjustment

79.82

70.77

71.06

68.20

78.20

68.73

61.31

53.44

49.89

33.42

Changes in Working Capital

-21.34

-22.19

-99.42

17.93

-25.75

-47.03

-24.09

-33.89

-30.73

-27.76

Cash after chg. in Working capital

233.46

176.21

83.85

193.91

145.29

121.77

121.98

85.86

51.38

37.13

Interest Paid

0.00

Tax Paid

-37.32

-28.91

-21.92

-19.51

-20.02

-14.94

-26.56

-13.56

-6.95

-8.73

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-29.35

-59.33

-71.09

-96.29

-87.40

-102.30

-104.67

-58.04

-47.74

-73.60

Net Fixed Assets

-49.10

-62.81

-72.64

-92.88

-46.34

-88.99

-97.81

-49.27

-86.20

-65.29

Net Investments

-1.46

-1.68

1.18

-7.30

-0.01

-6.49

0.51

1.79

17.69

-3.23

Others

21.21

5.16

0.37

3.89

-41.05

-6.82

-7.37

-10.56

20.77

-5.08

Cash from Financing Activity

-167.76

-86.96

9.12

-78.42

-36.79

-5.49

10.76

-16.33

2.98

45.13

Net Cash Inflow / Outflow

-0.96

1.01

-0.04

-0.31

1.07

-0.97

1.52

-2.07

-0.33

-0.06

Opening Cash & Equivalents

3.94

2.93

2.97

3.28

3.43

4.40

2.88

4.94

5.27

3.65

Closing Cash & Equivalent

2.98

3.94

2.93

2.97

4.50

3.43

4.40

2.88

4.94

3.59

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11 Mar 10 Mar 09 Mar 08
Cash From Operating Activity 250.74 143.09 69.77 174.75 133.29 104.59 20.56 59.12 64.90 28.39 PBT 185.29 131.02 124.50 116.01 95.27 99.72 33.11 47.40 26.04 20.09 Adjustment 86.84 75.20 75.12 71.63 79.30 69.40 38.76 38.77 41.71 27.51 Changes in Working Capital 19.49 -33.49 -105.19 8.47 -21.25 -49.58 -40.22 -13.27 2.39 -15.17 Cash after chg. in Working capital 291.62 172.74 94.44 196.11 153.33 119.53 31.65 72.90 70.14 32.43 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -40.88 -29.64 -24.67 -21.36 -20.03 -14.94 -11.09 -13.80 -5.24 -4.05 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -33.21 -61.67 -73.54 -106.98 -98.79 -107.01 -76.36 -30.46 -11.51 -33.16 Net Fixed Assets -49.10 -62.81 -72.64 -92.88 -46.34 -322.27 -65.29 -22.98 -19.64 -21.98 Net Investments -1.46 -1.68 1.18 -7.30 -0.01 13.50 -3.23 0.00 12.15 -12.18 Others 17.35 2.82 -2.08 -6.80 -52.44 201.76 -7.84 -7.48 -4.02 1.00 Cash from Financing Activity -215.41 -80.07 3.92 -68.23 -33.26 1.46 52.55 -23.62 -53.92 3.61 Net Cash Inflow / Outflow 2.13 1.35 0.15 -0.45 1.24 -0.95 -3.25 5.04 -0.53 -1.16 Opening Cash & Equivalents 4.64 3.29 3.15 3.60 3.58 4.53 8.52 3.48 4.02 5.18 Closing Cash & Equivalent 6.77 4.64 3.29 3.15 4.82 3.58 5.27 8.52 3.49 4.02

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 11

Mar 10

Mar 09

Mar 08

Cash From Operating Activity

250.74

143.09

69.77

174.75

133.29

104.59

20.56

59.12

64.90

28.39

PBT

185.29

131.02

124.50

116.01

95.27

99.72

33.11

47.40

26.04

20.09

Adjustment

86.84

75.20

75.12

71.63

79.30

69.40

38.76

38.77

41.71

27.51

Changes in Working Capital

19.49

-33.49

-105.19

8.47

-21.25

-49.58

-40.22

-13.27

2.39

-15.17

Cash after chg. in Working capital

291.62

172.74

94.44

196.11

153.33

119.53

31.65

72.90

70.14

32.43

Interest Paid

0.00

Tax Paid

-40.88

-29.64

-24.67

-21.36

-20.03

-14.94

-11.09

-13.80

-5.24

-4.05

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-33.21

-61.67

-73.54

-106.98

-98.79

-107.01

-76.36

-30.46

-11.51

-33.16

Net Fixed Assets

-49.10

-62.81

-72.64

-92.88

-46.34

-322.27

-65.29

-22.98

-19.64

-21.98

Net Investments

-1.46

-1.68

1.18

-7.30

-0.01

13.50

-3.23

0.00

12.15

-12.18

Others

17.35

2.82

-2.08

-6.80

-52.44

201.76

-7.84

-7.48

-4.02

1.00

Cash from Financing Activity

-215.41

-80.07

3.92

-68.23

-33.26

1.46

52.55

-23.62

-53.92

3.61

Net Cash Inflow / Outflow

2.13

1.35

0.15

-0.45

1.24

-0.95

-3.25

5.04

-0.53

-1.16

Opening Cash & Equivalents

4.64

3.29

3.15

3.60

3.58

4.53

8.52

3.48

4.02

5.18

Closing Cash & Equivalent

6.77

4.64

3.29

3.15

4.82

3.58

5.27

8.52

3.49

4.02

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 66.72 54.98 183.69 162.20 144.66 125.41 103.61 85.73 72.87 64.63 ROA 9.54% 6.49% 6.04% 6.95% 6.56% 8.54% 7.75% 6.86% 3.98% 4.86% ROE 23.79% 18.34% 17.90% 20.47% 20.27% 27.98% 26.52% 23.78% 13.49% 15.10% ROCE 21.29% 17.39% 16.64% 18.03% 18.43% 20.80% 21.07% 19.39% 13.51% 13.52% Fixed Asset Turnover 1.71 1.63 1.39 1.59 1.73 1.88 1.97 1.93 1.79 1.65 Receivable days 100.60 100.66 101.27 92.25 98.01 90.90 85.86 81.57 79.63 85.24 Inventory Days 59.73 60.46 69.69 54.75 49.94 43.59 46.69 49.16 47.05 49.46 Payable days 67.96 68.73 71.92 65.41 62.49 57.39 61.49 55.79 52.45 55.11 Cash Conversion Cycle 92.38 92.40 99.04 81.59 85.46 77.10 71.06 74.93 74.24 79.59 Total Debt/Equity 0.59 0.91 1.19 1.16 1.23 1.43 1.51 1.54 1.69 1.42 Interest Cover 5.90 4.11 4.09 3.83 2.96 3.37 3.28 3.15 2.27 3.01

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

66.72

54.98

183.69

162.20

144.66

125.41

103.61

85.73

72.87

64.63

ROA

9.54%

6.49%

6.04%

6.95%

6.56%

8.54%

7.75%

6.86%

3.98%

4.86%

ROE

23.79%

18.34%

17.90%

20.47%

20.27%

27.98%

26.52%

23.78%

13.49%

15.10%

ROCE

21.29%

17.39%

16.64%

18.03%

18.43%

20.80%

21.07%

19.39%

13.51%

13.52%

Fixed Asset Turnover

1.71

1.63

1.39

1.59

1.73

1.88

1.97

1.93

1.79

1.65

Receivable days

100.60

100.66

101.27

92.25

98.01

90.90

85.86

81.57

79.63

85.24

Inventory Days

59.73

60.46

69.69

54.75

49.94

43.59

46.69

49.16

47.05

49.46

Payable days

67.96

68.73

71.92

65.41

62.49

57.39

61.49

55.79

52.45

55.11

Cash Conversion Cycle

92.38

92.40

99.04

81.59

85.46

77.10

71.06

74.93

74.24

79.59

Total Debt/Equity

0.59

0.91

1.19

1.16

1.23

1.43

1.51

1.54

1.69

1.42

Interest Cover

5.90

4.11

4.09

3.83

2.96

3.37

3.28

3.15

2.27

3.01

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11 Mar 10 Mar 09 Mar 08
Book Value (Rs.) 70.01 57.61 193.12 167.72 147.58 127.25 67.37 60.47 52.63 47.61 ROA 9.33% 6.31% 6.38% 7.13% 6.53% 10.13% 4.99% 6.92% 4.29% 3.78% ROE 23.65% 17.97% 19.24% 21.60% 20.65% 32.78% 15.18% 21.09% 14.97% 14.08% ROCE 21.39% 17.01% 17.31% 18.50% 18.33% 23.93% 13.12% 20.30% 16.30% 11.03% Fixed Asset Turnover 1.81 1.66 1.44 1.64 1.75 2.19 1.45 1.57 1.42 1.26 Receivable days 95.71 97.45 97.10 89.05 95.59 67.25 82.06 83.04 95.17 98.73 Inventory Days 57.80 61.36 70.52 54.97 50.69 39.52 54.05 45.23 55.64 69.71 Payable days 64.68 68.08 73.82 67.66 65.68 45.51 45.97 46.92 62.87 59.81 Cash Conversion Cycle 88.83 90.73 93.79 76.36 80.60 61.26 90.14 81.35 87.94 108.62 Total Debt/Equity 0.58 0.93 1.20 1.20 1.26 1.45 1.64 1.29 1.56 1.95 Interest Cover 5.95 4.01 4.25 3.90 2.98 3.36 2.93 3.54 1.98 2.39

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 11

Mar 10

Mar 09

Mar 08

Book Value (Rs.)

70.01

57.61

193.12

167.72

147.58

127.25

67.37

60.47

52.63

47.61

ROA

9.33%

6.31%

6.38%

7.13%

6.53%

10.13%

4.99%

6.92%

4.29%

3.78%

ROE

23.65%

17.97%

19.24%

21.60%

20.65%

32.78%

15.18%

21.09%

14.97%

14.08%

ROCE

21.39%

17.01%

17.31%

18.50%

18.33%

23.93%

13.12%

20.30%

16.30%

11.03%

Fixed Asset Turnover

1.81

1.66

1.44

1.64

1.75

2.19

1.45

1.57

1.42

1.26

Receivable days

95.71

97.45

97.10

89.05

95.59

67.25

82.06

83.04

95.17

98.73

Inventory Days

57.80

61.36

70.52

54.97

50.69

39.52

54.05

45.23

55.64

69.71

Payable days

64.68

68.08

73.82

67.66

65.68

45.51

45.97

46.92

62.87

59.81

Cash Conversion Cycle

88.83

90.73

93.79

76.36

80.60

61.26

90.14

81.35

87.94

108.62

Total Debt/Equity

0.58

0.93

1.20

1.26

1.45

1.64

1.29

1.56

1.95

Interest Cover

5.95

4.01

4.25

3.90

2.98

3.36

2.93

3.54

1.98

2.39

Aarti Drugs Ltd.

Pharmaceuticals & Drugs - API

BSE: 524348 | NSE: AARTIDRUGS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update

Aarti Drugs Ltd.

Pharmaceuticals & Drugs - API

BSE: 524348 | NSE: AARTIDRUGS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update